The role of CD40-CD154 interaction in cell immunoregulation - PubMed (original) (raw)
Review
. 2004 Jul-Aug;11(4):426-38.
doi: 10.1007/BF02256091.
Affiliations
- PMID: 15153777
- DOI: 10.1007/BF02256091
Review
The role of CD40-CD154 interaction in cell immunoregulation
Yufei Xu et al. J Biomed Sci. 2004 Jul-Aug.
Abstract
CD40, a member of the nerve growth factor/tumor necrosis factor receptor superfamily, and its ligand, CD154, play essential roles in cell immune responses. The results of many studies have indicated that CD40-CD154 interaction can upregulate costimulatory molecules, activate antigen-presenting cells (APCs), influence T-cell priming and T-cell-mediated effector functions as well as participate in the pathogenic processing of chronic inflammatory diseases, such as autoimmune diabetes, graft rejection, atherosclerosis, and cancer. Ligation of CD40 on cancer cells was also found to produce a direct growth-inhibitory effect through cell cycle blockage and/or apoptosis with no overt side effects on normal cells and treatment with CD154 can heighten tumor rejection immune response as well. However, systemic treatment with CD154 has some potential risks. Therefore, searching for efficient and safe strategies of CD154-based cancer therapy has been a hot topic in human cancer research. This review focuses on the latest discovered functions of CD40-CD154 interaction in cell immune responses and on the new findings of CD154-based human cancer therapy.
Copyright 2004 National Science Council, ROC and S. Karger AG, Basel
Similar articles
- Prospects for CD40-directed experimental therapy of human cancer.
Tong AW, Stone MJ. Tong AW, et al. Cancer Gene Ther. 2003 Jan;10(1):1-13. doi: 10.1038/sj.cgt.7700527. Cancer Gene Ther. 2003. PMID: 12489023 Review. - CD154 (CD40 ligand).
Schönbeck U, Mach F, Libby P. Schönbeck U, et al. Int J Biochem Cell Biol. 2000 Jul;32(7):687-93. doi: 10.1016/s1357-2725(00)00016-9. Int J Biochem Cell Biol. 2000. PMID: 10856699 - The CD40/CD154 receptor/ligand dyad.
Schönbeck U, Libby P. Schönbeck U, et al. Cell Mol Life Sci. 2001 Jan;58(1):4-43. doi: 10.1007/pl00000776. Cell Mol Life Sci. 2001. PMID: 11229815 Free PMC article. Review. - CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4.
Hewitson JP, Jenkins GR, Hamblin PA, Mountford AP. Hewitson JP, et al. J Immunol. 2006 Sep 1;177(5):3209-17. doi: 10.4049/jimmunol.177.5.3209. J Immunol. 2006. PMID: 16920960 Free PMC article.
Cited by
- A Critical Review about Different Vaccines against Classical Swine Fever Virus and Their Repercussions in Endemic Regions.
Coronado L, Perera CL, Rios L, Frías MT, Pérez LJ. Coronado L, et al. Vaccines (Basel). 2021 Feb 15;9(2):154. doi: 10.3390/vaccines9020154. Vaccines (Basel). 2021. PMID: 33671909 Free PMC article. Review. - Porvac® Subunit Vaccine E2-CD154 Induces Remarkable Rapid Protection against Classical Swine Fever Virus.
Sordo-Puga Y, Suárez-Pedroso M, Naranjo-Valdéz P, Pérez-Pérez D, Santana-Rodríguez E, Sardinas-Gonzalez T, Mendez-Orta MK, Duarte-Cano CA, Estrada-Garcia MP, Rodríguez-Moltó MP. Sordo-Puga Y, et al. Vaccines (Basel). 2021 Feb 17;9(2):167. doi: 10.3390/vaccines9020167. Vaccines (Basel). 2021. PMID: 33671399 Free PMC article. - Vitamin D decreases CD40L gene expression in ulcerative colitis patients: A randomized, double-blinded, placebo-controlled trial.
Sharifi A, Vahedi H, Honarvar MR, Amiriani T, Nikniaz Z, Rad EY, Hosseinzadeh-Attar MJ. Sharifi A, et al. Turk J Gastroenterol. 2020 Feb;31(2):99-104. doi: 10.5152/tjg.2020.181028. Turk J Gastroenterol. 2020. PMID: 32141817 Free PMC article. Clinical Trial. - Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.
Urquiza M, Melo-Cardenas J, Aguillon R, Kipps TJ, Castro JE. Urquiza M, et al. Hum Gene Ther. 2015 Jan;26(1):14-25. doi: 10.1089/hum.2014.015. Hum Gene Ther. 2015. PMID: 25382101 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous